Canyon Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seadrill
SDRL
|
+$186M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$26.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$21.1M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$58.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 31.73% |
| 2 | Real Estate | 18.25% |
| 3 | Materials | 17.49% |
| 4 | Healthcare | 9.2% |
| 5 | Consumer Discretionary | 5.53% |
Similar funds
Canyon Capital Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Canyon Capital Advisors held 32 positions worth $1.01B, up 50% from $677M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Canyon Capital Advisors deployed $175M of net new capital in Q2 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 250,000 shares worth $25.7M.
By sector, the portfolio is most concentrated in Energy at 32% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.
On the sell side, the largest reduction was Tenet Healthcare, an estimated $58.3M trimmed.
- Canyon Capital Advisors's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 250,000 shares worth $25.7M.
- Canyon Capital Advisors added most to Seadrill in Q2 2023, an estimated $186M increase.
- Canyon Capital Advisors's biggest Q2 2023 reduction was Tenet Healthcare, cutting an estimated $58.3M.
- Canyon Capital Advisors's ten largest holdings make up 90% of its $1.01B portfolio in Q2 2023.
- Canyon Capital Advisors opened 2 new positions and closed 0 in Q2 2023.
- Canyon Capital Advisors's portfolio value rose 50% quarter-over-quarter to $1.01B.
Based on Canyon Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.